October 25, 2016 6:18 AM ET

Healthcare Providers and Services

Company Overview of Onco360

Company Overview

Onco360 provides oncology pharmaceuticals and care management services for physicians, patients, payers, and pharmaceutical manufacturers in the United States. It offers OncoSource, a total sourcing solution that offers drug pedigree, and no clinical fragmentation (oral, injected, infused, and limited distribution products); OncoDose, a fulfillment model that delivers treatment day/dose dispensing, as well as stat and emergency dose capabilities; OncoMTM, a medication treatment management program that helps improve safety, reduce adverse events, and drive compliance. The company also provides OncoPaths, which facilitates concordance with pathways subject to NCCN, ASCO, or payer evidence-base...

410 Park Avenue

Suite 820

New York, NY 10022

United States

Founded in 2003





Key Executives for Onco360

Chief Executive Officer and President
Founder, Managing Partner and Director of Clinical Programs
Director of Pharmacy
Scientific Advisory Council Partner
Scientific Advisory Council Partner
Compensation as of Fiscal Year 2016.

Onco360 Key Developments

Taiho Oncology, Inc Selects Onco360 as Limited Distribution Pharmacy Network Participant for Lonsurf

Onco360 announced that it has been selected by Taiho Oncology Inc. (Taiho) as a limited distribution pharmacy network participant for LONSURF®(trifluridine and tipiracil). With the addition of LONSURF, Onco360 continues to grow its broad portfolio of limited distribution oncology medications. LONSURF is a combination of trifluridine, a nucleoside metabolic inhibitor, and tipiracil, a thymidine phosphorylase inhibitor, indicated for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

Pfizer, Inc Selects Onco360 as Limited Distribution Pharmacy Provider

Onco360 announced that it has been selected by Pfizer Inc. as a limited distribution pharmacy network participant for Ibrance (palbociclib), Pfizer's recently approved product for certain breast cancers. The addition of this medication marks another key product win for Onco360, which continues to grow its portfolio of limited distribution products.

Onco360 Plans to Close its Corporate Headquarters in Manhattan; to Invest About $2 million to Build Out and Equip 25,000 Square Feet of the Jeffersontown Facility for the New Headquarters

Onco360 plans to close its corporate headquarters in Manhattan and relocate it to Louisville summer 2015. The company chose Louisville because the city's transportation network allows it to quickly transport its products anywhere. Bad weather, including heavy snow storms, are more common in the Northeast, and they can bring transportation networks to a halt. Jardina said some current employees will relocate to Louisville from New York and other parts of the country, but most of the 150 jobs will come from company growth. The company will keep a presence in the Northeast by maintaining its pharmacy hub in Great Neck, N.Y. The company will invest about $2 million to build out and equip 25,000 square feet of the Jeffersontown facility for the new headquarters, which is expected to house 150 employees within the next 10 years. Onco360 has committed to creating 30 jobs within the first year of operation. KEDFA has preliminarily awarded the company $1.6 million in tax incentives.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Onco360, please visit www.onco360.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.